ISFIYA, Israel, Oct. 13, 2016 /PRNewswire/ -- Check-Cap Ltd.
(Nasdaq: CHEK, CHEKW), a clinical stage medical diagnostics
company, today announced upcoming presentations evaluating the
Company's ingestible capsule for preparation-free, colorectal
cancer screening.
Presentations will take place at the American College of
Gastroenterology (ACG) Annual Scientific Meeting taking place
October 14-19, in Las Vegas and the United European
Gastroenterology Week (UEG) taking place October 15-19, in Vienna:
- (Video Abstract #V9): "A Preparation-Free X-Ray Imaging Capsule
for Colon Cancer Screening", Seth A.
Gross, M.D., Associate Professor and Chief of
Gastroenterology at Tisch Hospital, NYU Langone Medical Center;
Monday Oct. 17, 4:45 p.m. PT – 6:00 p.m.
PT; Venetian Ballroom D
- (Poster # P0208): "A Novel Preparation-Free X-Ray Imaging
Capsule for Colon Cancer Screening: Correlation between Capsule and
Colonoscopic Clinical Findings", Nadir
Arber, M.D., Director of the Integrated Cancer Prevention
Center (ICPC) at Tel Aviv Sourasky Medical Center; Monday Oct. 17, 12:30 p.m.
CET – 1:30 p.m. CET; Hall X5:
Terminal 2
About Check-Cap
Check-Cap is a clinical-stage medical diagnostics company
developing the world's first ingestible capsule system for
preparation-free, less-invasive colorectal cancer screening.
The capsule utilizes innovative ultra-low dose X-ray and
wireless communication technologies to scan the inside of the colon
as it moves naturally, while the patient follows his or her normal
daily routine. After passage, the system generates a 3D
map of the inner surface of the colon which enables detection of
polyps and cancer. Designed to increase the willingness of
individuals to participate in recommended colorectal cancer
screening, the Check-Cap system addresses many frequently-cited
barriers, including laxative bowel preparation, invasiveness, and
sedation. The Check-Cap system is currently not cleared for
marketing in any jurisdiction.
Legal Notice Regarding Forward-Looking Statements
This press release contains "forward-looking statements."
Words such as "may," "should," "could," "would," "predicts,"
"potential," "continue," "expects," "anticipates," "future,"
"intends," "plans," "believes," "estimates," and similar
expressions, as well as statements in future tense, often signify
forward-looking statements. Forward-looking statements should not
be read as a guarantee of future performance or results and may not
be accurate indications of when such performance or results will be
achieved. Forward-looking statements are based on information that
the Company has when those statements are made or management's good
faith belief as of that time with respect to future events, and are
subject to risks and uncertainties that could cause actual
performance or results to differ materially from those expressed in
or suggested by the forward-looking statements. For a discussion of
these and other risks that could cause such differences and that
may affect the realization of forward-looking statements, please
refer to the "Special Note On Forward-looking Statements" and "Risk
Factors" in the Company's Annual Report on Form 20-F and other
filings with the Securities and Exchange Commission (SEC).
Investors and security holders are urged to read these documents
free of charge on the SEC's web site at
http://www.sec.gov. The Company assumes no obligation to
publicly update or revise its forward-looking statements as a
result of new information, future events or otherwise.
CONTACT:
Investors
David Carey
Lazar Partners Ltd.
212-867-1768
dcarey@lazarpartners.com
Media
Erich Sandoval
Lazar Partners Ltd.
917-497-2867
esandoval@lazarpartners.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/check-cap-announces-upcoming-presentations-evaluating-preparation-free-colorectal-cancer-screening-capsule-300343581.html
SOURCE Check-Cap Ltd.